Otenzepad
Otenzepad[edit]
Otenzepad is a pharmacological agent classified as a muscarinic receptor antagonist. It is primarily used in research settings to study the muscarinic acetylcholine receptor subtypes, particularly the M2 receptor.
Mechanism of Action[edit]
Otenzepad functions by selectively inhibiting the M2 subtype of the muscarinic acetylcholine receptors. These receptors are part of the G protein-coupled receptor family and are involved in various physiological processes, including the regulation of cardiac function and smooth muscle contraction.
Pharmacological Effects[edit]
The blockade of M2 receptors by Otenzepad leads to an increase in heart rate and a decrease in smooth muscle contraction. This makes it a valuable tool in cardiovascular research, particularly in studies investigating the role of the parasympathetic nervous system in heart function.
Research Applications[edit]
Otenzepad is used extensively in laboratory settings to dissect the roles of different muscarinic receptor subtypes. Its selectivity for the M2 receptor allows researchers to study the specific effects of M2 receptor inhibition without affecting other muscarinic receptors.
Safety and Handling[edit]
As with many research chemicals, Otenzepad should be handled with care. Appropriate safety protocols should be followed to prevent exposure, and it should only be used by trained personnel in a controlled environment.
